1. Home
  2. SOTK vs ASRT Comparison

SOTK vs ASRT Comparison

Compare SOTK & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sono-Tek Corporation

SOTK

Sono-Tek Corporation

HOLD

Current Price

$4.14

Market Cap

65.7M

Sector

Technology

ML Signal

HOLD

Logo Assertio Holdings Inc.

ASRT

Assertio Holdings Inc.

HOLD

Current Price

$11.48

Market Cap

75.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SOTK
ASRT
Founded
1975
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
65.7M
75.1M
IPO Year
1987
1997

Fundamental Metrics

Financial Performance
Metric
SOTK
ASRT
Price
$4.14
$11.48
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
N/A
$35.00
AVG Volume (30 Days)
25.1K
69.5K
Earning Date
01-13-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
42.86
N/A
EPS
0.10
N/A
Revenue
$20,420,804.00
$137,354,000.00
Revenue This Year
$2.67
N/A
Revenue Next Year
$8.20
N/A
P/E Ratio
$42.30
N/A
Revenue Growth
1.34
9.22
52 Week Low
$3.23
$7.71
52 Week High
$5.15
$15.15

Technical Indicators

Market Signals
Indicator
SOTK
ASRT
Relative Strength Index (RSI) 52.36 87.55
Support Level $4.02 $9.11
Resistance Level $4.37 $10.39
Average True Range (ATR) 0.20 0.61
MACD 0.01 0.14
Stochastic Oscillator 30.44 91.03

Price Performance

Historical Comparison
SOTK
ASRT

About SOTK Sono-Tek Corporation

Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: